Publication list
2024
Tóth, E.,
Orbán-Kálmándi, R.,
Bagoly, Z.,
Lóczi, L.,
Deli, T.,
Török, O.,
Deliné Molnár, S.,
Baráth, S.,
Singh, P.,
Hevessy, Z.,
Katona, É.,
Fagyas, M.,
Szabó, A.,
Molnár, S.,
Krasznai, Z.:
Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Front. Immunol. 15 1-10, 2024.
Journal metrics:
Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
Mátrai, Á.,
Varga, Á.,
Baráth, B.,
Ványolos, E.,
Orbán-Kálmándi, R.,
Lóczi, L.,
Bagoly, Z.,
Jouppila, A.,
Lassila, R.,
Németh, N.,
Deák, Á.:
Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model.
J Thromb Thrombolysis. [Epub ahead of print]2024.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine (2023)
Q2 Hematology (2023)
Lóczi, L.,
P. Szabó, R.,
Orbán-Kálmándi, R.,
Hodossy-Takács, R.,
Szilvási, A.,
Szalai, Z.,
Nagy, G.,
Antal-Szalmás, P.,
Nemes, B.,
Bagoly, Z.:
Increased thrombin generation in kidney transplant recipients with donor-specific antibodies directed against human leukocyte antigens.
Front. Immunol. "Accepted by Publisher"2024.
Journal metrics:
Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
Ghansah, H.,
Orbán-Kálmándi, R.,
Bekéné Debreceni, I.,
Katona, É.,
Rejtő, L.,
Váróczy, L.,
Lóczi, L.,
Laat, B.,
Huskens, D.,
Kappelmayer, J.,
Bagoly, Z.:
Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Thromb. Res. 234 12-20, 2024.
2023
Stercel, V.,
Lóczi, L.,
Kadenczki, O.,
Nemes, É.,
Nagy, B.,
Hodossy-Takács, R.,
Szabó, A.,
Fagyas, M.,
Kappelmayer, J.,
Szabó, T.,
Bagoly, Z.:
Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
Front. Immunol. 14 1-12, 2023.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
Ghansah, H.,
Bekéné Debreceni, I.,
Váróczy, L.,
Rejtő, L.,
Lóczi, L.,
Bagoly, Z.,
Kappelmayer, J.:
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C.
Thromb. Res. 223 44-52, 2023.
2022
Székely, E.,
Orbán-Kálmándi, R.,
Szegedi, I.,
Katona, É.,
Baráth, B.,
Czuriga-Kovács, K.,
Lóczi, L.,
Molnárné Vasas, N.,
Fekete, I.,
Fekete, K.,
Berényi, E.,
Oláh, L.,
Csiba, L.,
Bagoly, Z.:
Low [alfa]2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
Front. Cardiovasc. Med. 9 1-14, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Lóczi, L.,
Orbán-Kálmándi, R.,
Árokszállási, T.,
Fekete, I.,
Fekete, K.,
Héja, M.,
Tóth, J.,
Csiba, L.,
Bagoly, Z.:
Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage.
Front. Neurol. 13 1-12, 2022.
Journal metrics:
Q2 Neurology
Q2 Neurology (clinical)
2020
updated: 2024-11-08, 01:34
